Results

Total Results: 1,192 records

Showing results for "short".

61. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
    January 01, 2010 - appropriate, and sustained behavioral and educational intervention may be associated with improved short-term … a systematic evidence base and are instead supported by small case series, single cases, or small, short-term … on core symptoms (e.g. social deficits, communication deficits and repetitive behaviors), in the short … • Changes in short-term targeted outcome areas, including social skills/interaction, language and … We have defined the timing of outcomes to be studied as follows: short-term outcomes will be considered

62. Cer-250-Cannabis-2024-Surv-Rep-Update-Table-E5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
    January 01, 2024 - NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … 66) Inhaled CBD- 0 mg/d Inhaled THC- 236.5 mg/d (IQR 55 to 495) Median 13 weeks for PROMIS-29 group Short … Median 20 (IQR 20-25) mg CBD/120 (IQR 110-205) mg THC 24 (6 months) Short Pain VAS (0-10 scale [median … treatment Mean (SD) A: 6.2 (2.4) sprays/day (16.74 mg THC/15.5 mg CBD) B: MME 69.4 (38.9) mg/day 24 Short

63. Opioid Treatments for Chronic Pain Research Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
    December 19, 2018 - In patients with chronic pain, what is the comparative effectiveness of short-acting versus long-acting … In patients with chronic pain, what is the comparative effectiveness of short- plus long-acting opioids … Results will be stratified according to short-term (1 to 6 months), intermediate term (6 to 12 months … harms; doses of opioids used 3d Adults (age ≥18 years) with various types of chronic pain Short … Results will be stratified according to short-term (1 to 6 months), intermediate term (6 to 12 months

64. Weight-Loss-Surgery Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_executive.pdf
    June 01, 2013 - effective than conventional nonsurgical therapy at lowering blood sugar to improve diabetes in the short … What are the potential short-term adverse effects and/or complications associated with bariatric surgery … How do the long-term benefits and harms of bariatric surgery compare to short-term outcomes (within … The evidence for both short- and long-term outcomes was assessed. … Documented short- and long-term benefits and harms of surgical procedures were compared to answer

65. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
    January 01, 2022 - NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … an add-on treatment Mean (SD) A: 16.6 (6.5) mg THC/15.4 (4.1) mg CBD/day B: 17.2 (7.6) mg THC/day 24 Short … Enjoyment, General Activity; RR = relative risk; SD = standard deviation; SE = standard error; SF-36 = short

66. Multiple-Sclerosis Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
    April 01, 2015 - This information would extend understanding beyond the short-term trials examined in the 2013 Cochrane … • The majority of discontinuation tends to occur in the short term (2-3 years from start). … Majority of discontinuations occur early/short term. … Long-term events do not differ from short- term events. … Similarly, overall long-term harms were found to be no different from short-term harms.

67. REQUEST FOR TASK ORDER (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
    April 01, 2010 - or a long-acting opiate, or k) both a short-acting and Use of chemotherapy was defined using the codes … Received an outpatient prescription for) both a short-acting and a long-acting opiate. … cThe denominator for death in a short-term hospital includes only those patients who have died within … opiateb 4,411 (20.5) 2,780 (22.7) 896 (27.2) 773 (26.9) Rx of a short or long-acting opiateb 5,277 … Association of physician and hospital characteristics on the use of opiates (long or short-acting)

68. Cannabis-2022-Update-Surv-Rep-1-App-F-5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
    January 01, 2022 - NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … an add-on treatment Mean (SD) A: 16.6 (6.5) mg THC/15.4 (4.1) mg CBD/day B: 17.2 (7.6) mg THC/day 24 Short … treatment Mean (SD) A: 6.2 (2.4) sprays/day (16.74 mg THC/15.5 mg CBD) B: MME 69.4 (38.9) mg/day 24 Short … PIX = pain intensity index; RR = relative risk; SD = standard deviation; SE = standard error; SF-36 = short

69. Cannabis-2022-Surv-Rep-3-Table-F5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
    January 01, 2022 - NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … an add-on treatment Mean (SD) A: 16.6 (6.5) mg THC/15.4 (4.1) mg CBD/day B: 17.2 (7.6) mg THC/day 24 Short … treatment Mean (SD) A: 6.2 (2.4) sprays/day (16.74 mg THC/15.5 mg CBD) B: MME 69.4 (38.9) mg/day 24 Short … PIX = pain intensity index; RR = relative risk; SD = standard deviation; SE = standard error; SF-36 = short

70. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting_research-protocol.pdf
    August 19, 2011 - when compared to angiography-guided PCI—on the diagnostic thinking and therapeutic decisionmaking, short-term … compare to each other in their effects on the diagnostic thinking and therapeutic decisionmaking, short-term … They are as follows: • Short-term (≤30 days) outcomes: o In-hospital procedural outcomes  … procedure optimization and assessment of immediate results in patients undergoing PCI, and improve short-term … Framework, Methods, and Results section Diagnostic thinking, therapeutic decisionmaking, and short

71. Cer-250-Cannabis-2025-Surv-Rep-Update-Table-E5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-table-e5.xlsx
    January 01, 2025 - NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs. … 66) Inhaled CBD- 0 mg/d Inhaled THC- 236.5 mg/d (IQR 55 to 495) Median 13 weeks for PROMIS-29 group Short … Median 20 (IQR 20-25) mg CBD/120 (IQR 110-205) mg THC 24 (6 months) Short Pain VAS (0-10 scale [median … treatment Mean (SD) A: 6.2 (2.4) sprays/day (16.74 mg THC/15.5 mg CBD) B: MME 69.4 (38.9) mg/day 24 Short

72. Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic Review. Evidence Summary. (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-200-post-acs-depression.pdf
    November 01, 2017 - Direct None detected MACE 2 studies RCT Inconsistent Imprecisea Inconsistent results; no effect to short-term … benefit (HR 0.25); short- term benefit was not sustained in long-term followup Insufficient 307 … MI=myocardial infarction; NR=not reported; RCT=randomized controlled trial; ROB=risk of bias; SF-12=Short … MCS=mental component summary; OR=odds ratio; RCT=randomized controlled trial; ROB=risk of bias; SF-12=Short … Some data within our review also suggest that very short questionnaires (1-2 questions) may perform

73. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
    May 29, 2025 - NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 week (3 months) Short A vs. … Enjoyment, General Activity; RR = relative risk; SD = standard deviation; SE = standard error; SF-36 = short

74. Appendix-E-Table-E5 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
    May 29, 2025 - NR + 3.02 mg/d 26 (6 months) Short and intermediate A vs. B vs. … NA CBD: 202.18 (SD 345.23) 12 week (3 months) Short A vs. … Enjoyment, General Activity; RR = relative risk; SD = standard deviation; SE = standard error; SF-36 = short

75. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
    February 01, 2012 - Do FGAs and SGAs differ in other short- and long- term outcomes when used in children, youth, and young … Short-term is defined as outcomes occurring within 6 months; long-term is defined as outcomes occurring … Key Question 3: Short- and long-term outcomes. … Short- and long-term outcomes were reported in nine studies examining pervasive developmental disorders … Summary of the strength of evidence for other short- and long-term outcomes (Key Question 3) Outcome

76. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
    April 01, 2022 - (KQ 1a) or long-term (KQ 2a) pain or function; harms by dose or duration (KQ 2b); long- versus short … placebo, short-term pain Opioids associated with small improvement in short-term pain • SOE: High … placebo, short-term function Opioids associated with small improvement in short-term function • … Long- vs. short- acting opioids Long-acting opioids associated with increased risk of overdose vs … . short-acting opioids • SOE: Low, based on 1 cohort study 1 case-control study6 (2,311 cases)

77. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
    September 01, 2009 - Do these regimens differ in reaching LDL targets (or other surrogate markers), short- term side effects … Most of the evidence originates from short-term studies aimed at biochemical measures and therefore is … LDL-c Targets, Short-Term Side Effects, Tolerability, and Adherence Surrogate markers are biological … Most trials had a short duration of treatment and followup. … Short-duration trials are unlikely to accrue sufficient adverse events, particularly those with longer

78. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
    October 01, 2007 - Adjunctive medical therapies, such as short-term intravenous or oral antiplatelet drugs, or long-term … Short-term/procedural outcomes For consistency, throughout this document, we present results in the … Short-term procedural survival after PCI generally exceeded that of CABG in both earlier and more recent … Comparative effectiveness objective outcomes and subjective outcomes Short-term outcomes Procedural … - These trials showed similar outcomes after PCI and CABG over a relatively short followup period.

79. CER 218 Disposition of Comments: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
    April 23, 2019 - For example, on page ES-1, in the 4th paragraph the following statement appears: “Short-term RCTs … Attempting to concisely summarize the short-term data, we erroneously conflated information from RCTs … Our review did not evaluate and does not include a section on the efficacy of short-term osteoporosis … A review of the evidence on short-term treatment was outside the scope of this review. … Limited information about short-term efficacy was included in the introduction to provide context for

80. Misuse of Prescription Stimulants in Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
    September 13, 2024 - prescription stimulant medications in adults to understand the patterns / trends in misuse and the short … • Exposure  Specific prescription stimulant(s), if named • Comparator, if applicable • Outcome o Short-term … IndexTermsFilt: ("Health Outcomes")) OR (IndexTermsFilt: ("Mental Health Outcomes"))) OR ((title: ("short … consequence)) OR (title: (consequences)) OR (title: (sequala)) OR (title: (sequalae))) OR ((abstract: ("short